ASSESSING THE RISK FOR AUTOIMMUNE DISORDERS FOLLOWING USE OF THE QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE: THE ONTARIO GRADE 8 HPV VACCINE COHORT STUDY

Introduction: In 2007 Ontario implemented a grade 8 quadrivalent human papillomavirus (qHPV) vaccination program targeting the virus that causes cervical cancer. Despite being 6 years post-implementation, few post-licensure studies have assessed the safety of the qHPV vaccine in this adolescent popu...

Full description

Bibliographic Details
Main Author: Liu, Yiran
Other Authors: Queen's University (Kingston, Ont.). Theses (Queen's University (Kingston, Ont.))
Language:en
en
Published: 2014
Subjects:
HPV
Online Access:http://hdl.handle.net/1974/12071